Bausch Health Companies Inc. (TSX:BHC)

Canada flag Canada · Delayed Price · Currency is CAD
6.55
-0.27 (-3.96%)
May 6, 2025, 4:00 PM EDT
-38.67%
Market Cap 2.41B
Revenue (ttm) 13.99B
Net Income (ttm) -57.49M
Shares Out n/a
EPS (ttm) -0.16
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 393,612
Average Volume 511,711
Open 6.79
Previous Close 6.82
Day's Range 6.47 - 6.95
52-Week Range 5.45 - 13.74
Beta 0.43
RSI 36.11
Earnings Date Apr 30, 2025

About Bausch Health Companies

Bausch Health Companies Inc. operates as a diversified specialty pharmaceutical and medical device company, develops, manufactures, and markets a range of products primarily in gastroenterology, hepatology, neurology, dermatology, generic pharmaceuticals, over-the-counter (OTC) products, aesthetic medical devices, and eye health in the United States and internationally. The company operates through five segments: Salix, International, Solta Medical, Diversified, and Bausch + Lomb. The Salix segment provides gastroenterology products. The Intern... [Read more]

Sector Healthcare
CEO Thomas Appio
Employees 20,700
Stock Exchange Toronto Stock Exchange
Ticker Symbol BHC
Full Company Profile

Financial Performance

In 2024, Bausch Health Companies's revenue was $9.63 billion, an increase of 9.91% compared to the previous year's $8.76 billion. Losses were -$46.00 million, -92.23% less than in 2023.

Financial numbers in USD Financial Statements

News

Xifaxan(R) (rifaximin) Treatment Following Overt Hepatic Encephalopathy (OHE) Hospitalization Associated with Reduced Risk of 30-Day OHE Rehospitalization

New analysis suggests efficacy of Xifaxan to mitigate OHE rehospitalizations irrespective of treatment history LAVAL, QC / ACCESS Newswire / May 6, 2025 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:B...

18 hours ago - Accesswire

Bausch Health Companies Inc. (BHC) Q1 2025 Earnings Call Transcript

Bausch Health Companies Inc. (NYSE:BHC) Q1 2025 Earnings Conference Call April 30, 2025 5:00 PM ETCompany ParticipantsGaren Sarafian - IRThomas Appio -...

6 days ago - Seeking Alpha

Bausch Health Companies Inc. 2025 Q1 - Results - Earnings Call Presentation

The following slide deck was published by Bausch Health Companies Inc.

6 days ago - Seeking Alpha

Bausch Health Announces First Quarter 2025 Results

First Quarter Consolidated Revenues of $2.26 billion, up 5% on a Reported basis and 6% on an Organic (non-GAAP) 1 basis over the prior year period GAAP Net Loss Attributable to Bausch Health Companies...

6 days ago - Accesswire

Bausch Health Announces Health Canada Clearance of Solta Medical's Thermage(R) FLX System

A Long-Awaited Advancement in Non-Invasive Radiofrequency Skin Tightening Is Now Approved for the Canadian Market LAVAL, QC / ACCESS Newswire / April 29, 2025 / Bausch Health Companies Inc. (NYSE:BHC)...

7 days ago - Accesswire

Notable healthcare headlines for the week: Merck, Roche and Bausch Health in focus

Wall Street powered to its second-best weekly advance of 2025 on Friday, with the benchmark S&P 500 (SP500) jumping nearly 5%. For the week, the S&P advanced +4

9 days ago - Seeking Alpha

Bausch Health Learns Icahn Has 34% Economic Interest in Shares

Activist investor Carl Icahn has tightened his hold on pharmaceutical company Bausch Health.

14 days ago - WSJ

Bausch Health says Carl Icahn has exposure to about 34% of company's shares

Billionaire Carl Icahn has a total economic exposure of about 34% to Bausch Health's common shares, the healthcare firm said in a filing on Tuesday.

14 days ago - Reuters

Bausch Health Announces Filing of Supplement to Proxy Statement

Supplement In Response to Company Learning that Carl Icahn and Affiliates Have Cash-Settled Equity Swaps for Approximately 90 Million of Its Common Shares LAVAL, QC / ACCESS Newswire / April 22, 2025 ...

14 days ago - Accesswire

Bausch + Lomb Reports More Than 100 Million Units of Contacts Lenses, Lens Care and Eye Care Materials Collected Through ONE By ONE and Biotrue® Eye Care Recycling Programs

VAUGHAN, Ontario--(BUSINESS WIRE)--Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced its exclusive ...

15 days ago - Business Wire

U.S. District Court Grants Summary Judgment in Favor of FDA, Salix, and Teva, and Against Norwich

LAVAL, QC / ACCESS Newswire / April 17, 2025 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) (the "Company" or "Bausch Health"), and its gastroenterology business Salix Pharmaceuticals, Inc., today...

19 days ago - Accesswire

Bausch Health Companies Inc (BHC) Adopts Shareholder Rights Plan | BHC stock news

Bausch Health Companies Inc (BHC) Adopts Shareholder Rights Plan | BHC stock news

22 days ago - GuruFocus

Bausch Health Announces Adoption of Shareholder Rights Plan

LAVAL, QC / ACCESS Newswire / April 14, 2025 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) (the "Company" or "Bausch Health") announces today that its board of directors (the "Board") has approve...

22 days ago - Accesswire

Bausch Health Companies Inc (BHC) Launches 2025 ASPIRE HIGHER Scholarship Program | BHC stock news

Bausch Health Companies Inc (BHC) Launches 2025 ASPIRE HIGHER Scholarship Program | BHC stock news

26 days ago - GuruFocus

Bausch Health Announces Ortho Dermatologics 2025 ASPIRE HIGHER Scholarship Program

Bausch Health is offering scholarships to six students impacted by dermatologic conditions, with application submissions open through June 11, 2025 LAVAL, QC / ACCESS Newswire / April 10, 2025 / Bausc...

26 days ago - Accesswire

Bausch Health, Canada Inc. and the pan-Canadian Pharmaceutical Alliance Sign Letter of Intent for Public Drug Plan Coverage of (Pr)CABTREO(TM) (clindamycin phosphate, adapalene and benzoyl peroxide gel) Treatment for Acne Vulgaris

LAVAL, QC / ACCESS Newswire / April 9, 2025 / Bausch Health, Canada Inc., part of Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) today announced that it has signed a letter of intent with the pan-Ca...

27 days ago - Accesswire

Patient Voices Highlight the Realities of Living with Irritable Bowel Syndrome During IBS Awareness Month

Bausch Health's gastroenterology business, Salix Pharmaceuticals, recognizes the complexities of irritable bowel syndrome (IBS) and seeks to make a difference in how the condition is perceived, diagno...

4 weeks ago - Accesswire

Bausch Health Companies Inc (BHC) to Announce First Quarter Results on April 30, 2025

Bausch Health Companies Inc (BHC) to Announce First Quarter Results on April 30, 2025

5 weeks ago - GuruFocus

Bausch + Lomb recalls some of its implantable eye lenses

Bausch + Lomb said on Thursday it will recall some of its implantable eye lenses after receiving reports of complications, the cause of which could not immediately be known.

5 weeks ago - Reuters

Bausch + Lomb Recalls EnVista Intraocular Lenses

The Canadian eyecare company said Thursday that it has made a voluntary recall of its intraocular lenses on its enVista platform.

5 weeks ago - Market Watch